

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | desmosome organization (GO:0002934) | 6.47125373 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06221236 |
| 3 | L-phenylalanine catabolic process (GO:0006559) | 6.06221236 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.93917459 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.93917459 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.27186883 |
| 7 | intestinal epithelial cell development (GO:0060576) | 5.24244964 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 5.09297549 |
| 9 | GDP-mannose metabolic process (GO:0019673) | 4.90309045 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.78706672 |
| 11 | cysteine metabolic process (GO:0006534) | 4.49002390 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.48442649 |
| 13 | regulation of water loss via skin (GO:0033561) | 4.44610734 |
| 14 | glyoxylate metabolic process (GO:0046487) | 4.34457997 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.32959505 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.29931009 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 4.29931009 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 4.29931009 |
| 19 | intestinal cholesterol absorption (GO:0030299) | 4.28140631 |
| 20 | tryptophan metabolic process (GO:0006568) | 4.22122828 |
| 21 | bile acid biosynthetic process (GO:0006699) | 4.20935247 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.19445311 |
| 23 | protein carboxylation (GO:0018214) | 4.19445311 |
| 24 | establishment of skin barrier (GO:0061436) | 4.15230012 |
| 25 | phenol-containing compound catabolic process (GO:0019336) | 4.11052092 |
| 26 | alpha-linolenic acid metabolic process (GO:0036109) | 4.09241636 |
| 27 | kynurenine metabolic process (GO:0070189) | 4.04471226 |
| 28 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.03619527 |
| 29 | keratinocyte development (GO:0003334) | 4.02843572 |
| 30 | urea cycle (GO:0000050) | 3.99112402 |
| 31 | urea metabolic process (GO:0019627) | 3.99112402 |
| 32 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.97192183 |
| 33 | high-density lipoprotein particle remodeling (GO:0034375) | 3.91242475 |
| 34 | aromatic amino acid family metabolic process (GO:0009072) | 3.86327209 |
| 35 | multicellular organismal water homeostasis (GO:0050891) | 3.81157120 |
| 36 | bile acid metabolic process (GO:0008206) | 3.79899958 |
| 37 | regulation of triglyceride catabolic process (GO:0010896) | 3.78480300 |
| 38 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.76050600 |
| 39 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.74674907 |
| 40 | nitrogen cycle metabolic process (GO:0071941) | 3.74654642 |
| 41 | negative regulation of fibrinolysis (GO:0051918) | 3.74352817 |
| 42 | triglyceride homeostasis (GO:0070328) | 3.69401488 |
| 43 | acylglycerol homeostasis (GO:0055090) | 3.69401488 |
| 44 | regulation of cholesterol esterification (GO:0010872) | 3.64909500 |
| 45 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.64846131 |
| 46 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.64846131 |
| 47 | aldehyde catabolic process (GO:0046185) | 3.64278264 |
| 48 | complement activation, alternative pathway (GO:0006957) | 3.64100886 |
| 49 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.63660032 |
| 50 | hemidesmosome assembly (GO:0031581) | 3.61187348 |
| 51 | homocysteine metabolic process (GO:0050667) | 3.54422244 |
| 52 | phospholipid efflux (GO:0033700) | 3.54375970 |
| 53 | plasma lipoprotein particle clearance (GO:0034381) | 3.53639935 |
| 54 | tyrosine metabolic process (GO:0006570) | 3.53260669 |
| 55 | regulation of cholesterol homeostasis (GO:2000188) | 3.52386123 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.52288850 |
| 57 | lysine catabolic process (GO:0006554) | 3.51802797 |
| 58 | lysine metabolic process (GO:0006553) | 3.51802797 |
| 59 | regulation of protein activation cascade (GO:2000257) | 3.51332718 |
| 60 | intestinal absorption (GO:0050892) | 3.49859035 |
| 61 | amino-acid betaine metabolic process (GO:0006577) | 3.48728286 |
| 62 | serine family amino acid catabolic process (GO:0009071) | 3.48619772 |
| 63 | reverse cholesterol transport (GO:0043691) | 3.46668826 |
| 64 | bile acid and bile salt transport (GO:0015721) | 3.46375588 |
| 65 | plasma lipoprotein particle remodeling (GO:0034369) | 3.45739152 |
| 66 | protein-lipid complex remodeling (GO:0034368) | 3.45739152 |
| 67 | macromolecular complex remodeling (GO:0034367) | 3.45739152 |
| 68 | glutathione biosynthetic process (GO:0006750) | 3.40056983 |
| 69 | cellular ketone body metabolic process (GO:0046950) | 3.39581005 |
| 70 | negative regulation of cholesterol transport (GO:0032375) | 3.38817758 |
| 71 | negative regulation of sterol transport (GO:0032372) | 3.38817758 |
| 72 | fatty acid beta-oxidation (GO:0006635) | 3.36011046 |
| 73 | alpha-amino acid catabolic process (GO:1901606) | 3.34000504 |
| 74 | regulation of complement activation (GO:0030449) | 3.32114285 |
| 75 | drug transmembrane transport (GO:0006855) | 3.30430288 |
| 76 | urate metabolic process (GO:0046415) | 3.28173336 |
| 77 | cellular modified amino acid catabolic process (GO:0042219) | 3.25861697 |
| 78 | fatty acid oxidation (GO:0019395) | 3.23589184 |
| 79 | cellular amino acid catabolic process (GO:0009063) | 3.21441509 |
| 80 | water homeostasis (GO:0030104) | 3.21368101 |
| 81 | valine metabolic process (GO:0006573) | 3.21322368 |
| 82 | ribosomal small subunit biogenesis (GO:0042274) | 3.21220474 |
| 83 | cholesterol efflux (GO:0033344) | 3.19660586 |
| 84 | protein autoprocessing (GO:0016540) | 3.18900624 |
| 85 | lipid oxidation (GO:0034440) | 3.17240326 |
| 86 | fatty acid catabolic process (GO:0009062) | 3.15841956 |
| 87 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.15624513 |
| 88 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.14993212 |
| 89 | rRNA modification (GO:0000154) | 3.13272749 |
| 90 | indolalkylamine metabolic process (GO:0006586) | 3.12548539 |
| 91 | regulation of viral release from host cell (GO:1902186) | 3.12276233 |
| 92 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.11617742 |
| 93 | coenzyme catabolic process (GO:0009109) | 3.09142261 |
| 94 | cholesterol homeostasis (GO:0042632) | 3.08735084 |
| 95 | proline metabolic process (GO:0006560) | 3.08302240 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 3.07129847 |
| 97 | arginine metabolic process (GO:0006525) | 3.06620572 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.06519190 |
| 99 | cofactor catabolic process (GO:0051187) | 3.05932452 |
| 100 | organic acid catabolic process (GO:0016054) | 3.05304523 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.05304523 |
| 102 | sterol homeostasis (GO:0055092) | 3.04693537 |
| 103 | ATP synthesis coupled proton transport (GO:0015986) | 3.03962401 |
| 104 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.03962401 |
| 105 | monocarboxylic acid catabolic process (GO:0072329) | 3.03159815 |
| 106 | electron transport chain (GO:0022900) | 3.01999943 |
| 107 | diol metabolic process (GO:0034311) | 3.01986496 |
| 108 | cobalamin metabolic process (GO:0009235) | 3.01891945 |
| 109 | proline biosynthetic process (GO:0006561) | 3.01748360 |
| 110 | Golgi transport vesicle coating (GO:0048200) | 3.00497448 |
| 111 | COPI coating of Golgi vesicle (GO:0048205) | 3.00497448 |
| 112 | respiratory electron transport chain (GO:0022904) | 3.00109633 |
| 113 | glandular epithelial cell differentiation (GO:0002067) | 2.99616103 |
| 114 | cellular biogenic amine catabolic process (GO:0042402) | 2.98281728 |
| 115 | amine catabolic process (GO:0009310) | 2.98281728 |
| 116 | serine family amino acid metabolic process (GO:0009069) | 2.97680613 |
| 117 | benzene-containing compound metabolic process (GO:0042537) | 2.97346107 |
| 118 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.97297876 |
| 119 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.96165913 |
| 120 | drug catabolic process (GO:0042737) | 2.93887995 |
| 121 | lipoprotein metabolic process (GO:0042157) | 2.93721999 |
| 122 | ethanol oxidation (GO:0006069) | 2.93423107 |
| 123 | positive regulation of lipid catabolic process (GO:0050996) | 2.93090763 |
| 124 | tight junction assembly (GO:0070830) | 2.90030864 |
| 125 | cellular glucuronidation (GO:0052695) | 2.89273075 |
| 126 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.89244424 |
| 127 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88260633 |
| 128 | zinc ion transmembrane transport (GO:0071577) | 2.87801152 |
| 129 | ketone body metabolic process (GO:1902224) | 2.87635726 |
| 130 | primary alcohol catabolic process (GO:0034310) | 2.87542139 |
| 131 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.87373325 |
| 132 | acute-phase response (GO:0006953) | 2.87033460 |
| 133 | drug transport (GO:0015893) | 2.83591478 |
| 134 | fibrinolysis (GO:0042730) | 2.83157913 |
| 135 | glutathione derivative metabolic process (GO:1901685) | 2.83002379 |
| 136 | glutathione derivative biosynthetic process (GO:1901687) | 2.83002379 |
| 137 | imidazole-containing compound metabolic process (GO:0052803) | 2.82688685 |
| 138 | drug metabolic process (GO:0017144) | 2.82645498 |
| 139 | short-chain fatty acid metabolic process (GO:0046459) | 2.81682101 |
| 140 | phenylpropanoid metabolic process (GO:0009698) | 2.81271251 |
| 141 | ncRNA 3-end processing (GO:0043628) | 2.80774334 |
| 142 | respiratory chain complex IV assembly (GO:0008535) | 2.73241676 |
| 143 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.72806630 |
| 144 | glucuronate metabolic process (GO:0019585) | 2.71492960 |
| 145 | uronic acid metabolic process (GO:0006063) | 2.71492960 |
| 146 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.71390738 |
| 147 | cytochrome complex assembly (GO:0017004) | 2.70325745 |
| 148 | protein maturation by protein folding (GO:0022417) | 2.69345322 |
| 149 | auditory receptor cell differentiation (GO:0042491) | 2.68249530 |
| 150 | biotin metabolic process (GO:0006768) | 2.67724377 |
| 151 | transcytosis (GO:0045056) | 2.67709294 |
| 152 | phosphate ion homeostasis (GO:0055062) | 2.66842660 |
| 153 | trivalent inorganic anion homeostasis (GO:0072506) | 2.66842660 |
| 154 | positive regulation of epidermis development (GO:0045684) | 2.63378853 |
| 155 | sphingomyelin metabolic process (GO:0006684) | 2.62796413 |
| 156 | regulation of keratinocyte differentiation (GO:0045616) | 2.62780361 |
| 157 | protein localization to endoplasmic reticulum (GO:0070972) | 2.60433618 |
| 158 | gap junction assembly (GO:0016264) | 2.59287302 |
| 159 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.59102527 |
| 160 | nucleotide transmembrane transport (GO:1901679) | 2.58907663 |
| 161 | ectoderm development (GO:0007398) | 2.56985686 |
| 162 | pseudouridine synthesis (GO:0001522) | 2.56836348 |
| 163 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.56796729 |
| 164 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.56796729 |
| 165 | protein targeting to ER (GO:0045047) | 2.54978230 |
| 166 | hydrogen peroxide catabolic process (GO:0042744) | 2.54038580 |
| 167 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.52778961 |
| 168 | O-glycan processing (GO:0016266) | 2.52286684 |
| 169 | sphingosine metabolic process (GO:0006670) | 2.51772480 |
| 170 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.51234515 |
| 171 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.50066352 |
| 172 | cotranslational protein targeting to membrane (GO:0006613) | 2.48739207 |
| 173 | rRNA methylation (GO:0031167) | 2.46097577 |
| 174 | nucleoside transmembrane transport (GO:1901642) | 2.44317108 |
| 175 | regulation of mitochondrial translation (GO:0070129) | 2.44284355 |
| 176 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.44230055 |
| 177 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.44089263 |
| 178 | regulation of epidermal cell differentiation (GO:0045604) | 2.42782390 |
| 179 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.42455235 |
| 180 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.42455235 |
| 181 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.42194146 |
| 182 | glutathione metabolic process (GO:0006749) | 2.41666735 |
| 183 | vesicle targeting (GO:0006903) | 2.41629971 |
| 184 | vitamin transport (GO:0051180) | 2.41537857 |
| 185 | ER overload response (GO:0006983) | 2.41428175 |
| 186 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.41407600 |
| 187 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.41304852 |
| 188 | nitric oxide biosynthetic process (GO:0006809) | 2.37640066 |
| 189 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.37068980 |
| 190 | hydrogen peroxide metabolic process (GO:0042743) | 2.35223993 |
| 191 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.34698908 |
| 192 | translation (GO:0006412) | 2.34320403 |
| 193 | NADH metabolic process (GO:0006734) | 2.33820269 |
| 194 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.32271358 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.90616068 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.94123472 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.38969202 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.49238867 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.38774525 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34633093 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.14061145 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.71300262 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.28136932 |
| 10 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.63078457 |
| 11 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.43266614 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.39295994 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.32920328 |
| 14 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.27529319 |
| 15 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.16146759 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.13400423 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.10624656 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.09505003 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.07773247 |
| 20 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.06565553 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05142192 |
| 22 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.93259766 |
| 23 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.84893121 |
| 24 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.78952954 |
| 25 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.75269016 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.73482702 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.72527371 |
| 28 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.69772473 |
| 29 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.66862458 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63177403 |
| 31 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.55443984 |
| 32 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.54024395 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51728316 |
| 34 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50049737 |
| 35 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.48959564 |
| 36 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.48655641 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.46465257 |
| 38 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.45126442 |
| 39 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.43927171 |
| 40 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.42924304 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.42647292 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41227989 |
| 43 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.41075012 |
| 44 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.40917749 |
| 45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35752401 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.35718166 |
| 47 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35626124 |
| 48 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.35305041 |
| 49 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.33801422 |
| 50 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.33801422 |
| 51 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.33675635 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.32850257 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.31456960 |
| 54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.30777813 |
| 55 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.28570300 |
| 56 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.27272375 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.27260907 |
| 58 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.26625908 |
| 59 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.26198463 |
| 60 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.24344142 |
| 61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.22166619 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21586456 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19409153 |
| 64 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.18965837 |
| 65 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.18215441 |
| 66 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16793407 |
| 67 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.16238816 |
| 68 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15876293 |
| 69 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.15679232 |
| 70 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15525152 |
| 71 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.14386554 |
| 72 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.13530440 |
| 73 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12676239 |
| 74 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.12131985 |
| 75 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.09505618 |
| 76 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09463376 |
| 77 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.09440117 |
| 78 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.07679693 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07394935 |
| 80 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07280938 |
| 81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.07156976 |
| 82 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.06416096 |
| 83 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.05468357 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 1.05233213 |
| 85 | * TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.04772382 |
| 86 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04204860 |
| 87 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04049669 |
| 88 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.03619680 |
| 89 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.03310241 |
| 90 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02929108 |
| 91 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.02247540 |
| 92 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.01268433 |
| 93 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01135192 |
| 94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00519268 |
| 95 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00118376 |
| 96 | CHD1_26751641_Chip-Seq_LNCaP_Human | 1.00076090 |
| 97 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.00025119 |
| 98 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.99644050 |
| 99 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.99180870 |
| 100 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.99083769 |
| 101 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.98075253 |
| 102 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.97922506 |
| 103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97264009 |
| 104 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.96523641 |
| 105 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95561114 |
| 106 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.94108474 |
| 107 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.93434492 |
| 108 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.92720053 |
| 109 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.92443481 |
| 110 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91520194 |
| 111 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.90122567 |
| 112 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.89287071 |
| 113 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88887489 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.87868276 |
| 115 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87609089 |
| 116 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.87315194 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86855278 |
| 118 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86853191 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86577265 |
| 120 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.86564916 |
| 121 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.84402143 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.83894564 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.83231987 |
| 124 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.82800362 |
| 125 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82065411 |
| 126 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.81389027 |
| 127 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.81328198 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80558115 |
| 129 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.80292649 |
| 130 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79466019 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.79323883 |
| 132 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.78679770 |
| 133 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.78029790 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.78012269 |
| 135 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.77870294 |
| 136 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.77221890 |
| 137 | ATF3_27146783_Chip-Seq_COLON_Human | 0.76400369 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75527749 |
| 139 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.74749521 |
| 140 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.74717661 |
| 141 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.73801055 |
| 142 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.73139303 |
| 143 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72857885 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72005077 |
| 145 | * E2F1_20622854_ChIP-Seq_HELA_Human | 0.71849250 |
| 146 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.71704138 |
| 147 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.71159685 |
| 148 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.70402885 |
| 149 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.70364273 |
| 150 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.70231811 |
| 151 | P300_27268052_Chip-Seq_Bcells_Human | 0.70190801 |
| 152 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.69205356 |
| 153 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.69205356 |
| 154 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.69205356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.36180434 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 6.22557247 |
| 3 | MP0005360_urolithiasis | 5.83789076 |
| 4 | MP0005365_abnormal_bile_salt | 4.87177464 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 4.66976192 |
| 6 | MP0009379_abnormal_foot_pigmentation | 4.51178196 |
| 7 | MP0003806_abnormal_nucleotide_metabolis | 4.22172985 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.74203407 |
| 9 | MP0005083_abnormal_biliary_tract | 3.39502268 |
| 10 | MP0009840_abnormal_foam_cell | 3.23739674 |
| 11 | MP0003195_calcinosis | 3.07204606 |
| 12 | MP0003252_abnormal_bile_duct | 2.97723374 |
| 13 | MP0009780_abnormal_chondrocyte_physiolo | 2.94275186 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.87533760 |
| 15 | MP0005501_abnormal_skin_physiology | 2.80332267 |
| 16 | MP0005409_darkened_coat_color | 2.77674230 |
| 17 | MP0010329_abnormal_lipoprotein_level | 2.70831236 |
| 18 | MP0005332_abnormal_amino_acid | 2.39609827 |
| 19 | MP0003136_yellow_coat_color | 2.37619018 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.32420681 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 2.30562149 |
| 22 | MP0010678_abnormal_skin_adnexa | 2.25658073 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 2.18923681 |
| 24 | MP0002138_abnormal_hepatobiliary_system | 2.17035814 |
| 25 | MP0000579_abnormal_nail_morphology | 2.11533589 |
| 26 | MP0003941_abnormal_skin_development | 2.10118068 |
| 27 | MP0004381_abnormal_hair_follicle | 1.99294029 |
| 28 | MP0002118_abnormal_lipid_homeostasis | 1.85028042 |
| 29 | MP0009643_abnormal_urine_homeostasis | 1.84646860 |
| 30 | MP0002163_abnormal_gland_morphology | 1.82938107 |
| 31 | MP0000609_abnormal_liver_physiology | 1.81166387 |
| 32 | MP0002909_abnormal_adrenal_gland | 1.79717505 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.70088958 |
| 34 | MP0001216_abnormal_epidermal_layer | 1.68225328 |
| 35 | MP0005379_endocrine/exocrine_gland_phen | 1.67817781 |
| 36 | MP0005451_abnormal_body_composition | 1.67372470 |
| 37 | MP0003186_abnormal_redox_activity | 1.66889991 |
| 38 | MP0003693_abnormal_embryo_hatching | 1.64117928 |
| 39 | MP0000383_abnormal_hair_follicle | 1.63355618 |
| 40 | MP0003868_abnormal_feces_composition | 1.62471187 |
| 41 | MP0005319_abnormal_enzyme/_coenzyme | 1.61839171 |
| 42 | MP0000372_irregular_coat_pigmentation | 1.58334705 |
| 43 | MP0003724_increased_susceptibility_to | 1.54986330 |
| 44 | MP0001188_hyperpigmentation | 1.54916754 |
| 45 | MP0010771_integument_phenotype | 1.50830130 |
| 46 | MP0001764_abnormal_homeostasis | 1.48759772 |
| 47 | MP0005220_abnormal_exocrine_pancreas | 1.37651802 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 1.34260450 |
| 49 | MP0004043_abnormal_pH_regulation | 1.34085713 |
| 50 | MP0001664_abnormal_digestion | 1.26420938 |
| 51 | MP0003436_decreased_susceptibility_to | 1.24482930 |
| 52 | MP0001881_abnormal_mammary_gland | 1.24323393 |
| 53 | MP0005084_abnormal_gallbladder_morpholo | 1.23310328 |
| 54 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.21335577 |
| 55 | MP0000377_abnormal_hair_follicle | 1.21128614 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.20023511 |
| 57 | MP0001756_abnormal_urination | 1.17276070 |
| 58 | MP0000627_abnormal_mammary_gland | 1.14192667 |
| 59 | MP0001873_stomach_inflammation | 1.12939336 |
| 60 | MP0008469_abnormal_protein_level | 1.12652193 |
| 61 | MP0001849_ear_inflammation | 1.11165157 |
| 62 | MP0002277_abnormal_respiratory_mucosa | 1.10614320 |
| 63 | MP0005670_abnormal_white_adipose | 1.09905811 |
| 64 | MP0000467_abnormal_esophagus_morphology | 1.08763986 |
| 65 | MP0002060_abnormal_skin_morphology | 1.08758683 |
| 66 | MP0010352_gastrointestinal_tract_polyps | 1.08225713 |
| 67 | MP0003705_abnormal_hypodermis_morpholog | 1.07022019 |
| 68 | MP0002796_impaired_skin_barrier | 1.06929194 |
| 69 | MP0000598_abnormal_liver_morphology | 1.06166610 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.05508292 |
| 71 | MP0002254_reproductive_system_inflammat | 1.04944288 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.04923358 |
| 73 | MP0009764_decreased_sensitivity_to | 1.04497134 |
| 74 | MP0004782_abnormal_surfactant_physiolog | 1.02979473 |
| 75 | MP0009785_altered_susceptibility_to | 1.01530924 |
| 76 | MP0002234_abnormal_pharynx_morphology | 0.98480941 |
| 77 | MP0005408_hypopigmentation | 0.98324921 |
| 78 | MP0002693_abnormal_pancreas_physiology | 0.96615256 |
| 79 | MP0002160_abnormal_reproductive_system | 0.96598591 |
| 80 | MP0001944_abnormal_pancreas_morphology | 0.96560628 |
| 81 | MP0000427_abnormal_hair_cycle | 0.95576707 |
| 82 | MP0002078_abnormal_glucose_homeostasis | 0.95401217 |
| 83 | MP0003011_delayed_dark_adaptation | 0.95114108 |
| 84 | MP0002166_altered_tumor_susceptibility | 0.93465120 |
| 85 | MP0000015_abnormal_ear_pigmentation | 0.93383146 |
| 86 | MP0009642_abnormal_blood_homeostasis | 0.92096607 |
| 87 | MP0009763_increased_sensitivity_to | 0.89823541 |
| 88 | MP0005395_other_phenotype | 0.89389365 |
| 89 | MP0000490_abnormal_crypts_of | 0.89176474 |
| 90 | MP0005167_abnormal_blood-brain_barrier | 0.85772365 |
| 91 | MP0000678_abnormal_parathyroid_gland | 0.85752661 |
| 92 | MP0000367_abnormal_coat/_hair | 0.84834786 |
| 93 | MP0002136_abnormal_kidney_physiology | 0.84040552 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.83469706 |
| 95 | MP0000762_abnormal_tongue_morphology | 0.83089448 |
| 96 | MP0005377_hearing/vestibular/ear_phenot | 0.81352304 |
| 97 | MP0003878_abnormal_ear_physiology | 0.81352304 |
| 98 | MP0003183_abnormal_peptide_metabolism | 0.79841804 |
| 99 | MP0009697_abnormal_copulation | 0.79245116 |
| 100 | MP0002653_abnormal_ependyma_morphology | 0.78634805 |
| 101 | MP0004147_increased_porphyrin_level | 0.76257671 |
| 102 | MP0004264_abnormal_extraembryonic_tissu | 0.75999774 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.75829129 |
| 104 | MP0005334_abnormal_fat_pad | 0.75203230 |
| 105 | MP0006082_CNS_inflammation | 0.74752429 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.74677153 |
| 107 | MP0003045_fibrosis | 0.74463245 |
| 108 | MP0000477_abnormal_intestine_morphology | 0.74301238 |
| 109 | MP0000462_abnormal_digestive_system | 0.73481978 |
| 110 | MP0003879_abnormal_hair_cell | 0.73298225 |
| 111 | MP0001191_abnormal_skin_condition | 0.72854335 |
| 112 | MP0003283_abnormal_digestive_organ | 0.72524887 |
| 113 | MP0002168_other_aberrant_phenotype | 0.71740852 |
| 114 | MP0000566_synostosis | 0.71094558 |
| 115 | MP0003453_abnormal_keratinocyte_physiol | 0.70898798 |
| 116 | MP0000470_abnormal_stomach_morphology | 0.70152043 |
| 117 | MP0002736_abnormal_nociception_after | 0.70130007 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.69642643 |
| 119 | MP0005376_homeostasis/metabolism_phenot | 0.69498953 |
| 120 | MP0009931_abnormal_skin_appearance | 0.68192076 |
| 121 | MP0002419_abnormal_innate_immunity | 0.67253177 |
| 122 | MP0005647_abnormal_sex_gland | 0.66410794 |
| 123 | MP0005075_abnormal_melanosome_morpholog | 0.66193546 |
| 124 | MP0000604_amyloidosis | 0.65391444 |
| 125 | MP0005025_abnormal_response_to | 0.64069625 |
| 126 | MP0001765_abnormal_ion_homeostasis | 0.62566351 |
| 127 | MP0002098_abnormal_vibrissa_morphology | 0.62410871 |
| 128 | MP0003638_abnormal_response/metabolism_ | 0.61496065 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.61302066 |
| 130 | MP0002928_abnormal_bile_duct | 0.61011902 |
| 131 | MP0002877_abnormal_melanocyte_morpholog | 0.60803958 |
| 132 | MP0000613_abnormal_salivary_gland | 0.60195885 |
| 133 | MP0008004_abnormal_stomach_pH | 0.60135002 |
| 134 | MP0010155_abnormal_intestine_physiology | 0.60090004 |
| 135 | MP0001661_extended_life_span | 0.59450203 |
| 136 | MP0001542_abnormal_bone_strength | 0.59069643 |
| 137 | MP0005666_abnormal_adipose_tissue | 0.58956290 |
| 138 | MP0002876_abnormal_thyroid_physiology | 0.58716066 |
| 139 | MP0002295_abnormal_pulmonary_circulatio | 0.55944996 |
| 140 | MP0005448_abnormal_energy_balance | 0.55932421 |
| 141 | MP0003718_maternal_effect | 0.54651391 |
| 142 | MP0003953_abnormal_hormone_level | 0.54358117 |
| 143 | MP0005535_abnormal_body_temperature | 0.54123698 |
| 144 | MP0000249_abnormal_blood_vessel | 0.53305178 |
| 145 | MP0008260_abnormal_autophagy | 0.52911415 |
| 146 | MP0002132_abnormal_respiratory_system | 0.52778689 |
| 147 | MP0003172_abnormal_lysosome_physiology | 0.52764253 |
| 148 | MP0010386_abnormal_urinary_bladder | 0.52009944 |
| 149 | MP0002148_abnormal_hypersensitivity_rea | 0.51145385 |
| 150 | MP0005165_increased_susceptibility_to | 0.51128673 |
| 151 | MP0002971_abnormal_brown_adipose | 0.51104547 |
| 152 | MP0000685_abnormal_immune_system | 0.50839741 |
| 153 | MP0003075_altered_response_to | 0.50639563 |
| 154 | MP0000538_abnormal_urinary_bladder | 0.50383364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.31198863 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.99053139 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.95598543 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 4.85802859 |
| 5 | Xanthomatosis (HP:0000991) | 4.83733832 |
| 6 | Hypoglycemic coma (HP:0001325) | 4.71682651 |
| 7 | Deep venous thrombosis (HP:0002625) | 4.51184315 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.41656252 |
| 9 | Pili torti (HP:0003777) | 4.19172607 |
| 10 | Right ventricular cardiomyopathy (HP:0011663) | 4.14863516 |
| 11 | Joint hemorrhage (HP:0005261) | 3.87608160 |
| 12 | Testicular atrophy (HP:0000029) | 3.83856682 |
| 13 | Generalized aminoaciduria (HP:0002909) | 3.74223123 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 3.73132763 |
| 15 | Abnormality of the intrinsic pathway (HP:0010989) | 3.70298223 |
| 16 | Ketosis (HP:0001946) | 3.61517199 |
| 17 | Hyperammonemia (HP:0001987) | 3.61201099 |
| 18 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.60343218 |
| 19 | Hyperglycinuria (HP:0003108) | 3.59597286 |
| 20 | Abnormality of the common coagulation pathway (HP:0010990) | 3.58925560 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.58085929 |
| 22 | Complement deficiency (HP:0004431) | 3.56852743 |
| 23 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.53079181 |
| 24 | Hypoglycemic seizures (HP:0002173) | 3.51934627 |
| 25 | Fat malabsorption (HP:0002630) | 3.39686664 |
| 26 | Hypolipoproteinemia (HP:0010981) | 3.33384099 |
| 27 | Hyperglycinemia (HP:0002154) | 3.30554625 |
| 28 | Abnormality of purine metabolism (HP:0004352) | 3.29436400 |
| 29 | Ketoacidosis (HP:0001993) | 3.28366371 |
| 30 | Gout (HP:0001997) | 3.24309805 |
| 31 | Lip pit (HP:0100267) | 3.24115384 |
| 32 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.21979818 |
| 33 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.21979818 |
| 34 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.20936007 |
| 35 | Vacuolated lymphocytes (HP:0001922) | 3.18779108 |
| 36 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.18258540 |
| 37 | Abnormality of glycine metabolism (HP:0010895) | 3.18258540 |
| 38 | Symptomatic seizures (HP:0011145) | 3.14413631 |
| 39 | Abnormality of vitamin metabolism (HP:0100508) | 3.13261793 |
| 40 | Sparse eyelashes (HP:0000653) | 3.12746774 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.12064020 |
| 42 | Amelogenesis imperfecta (HP:0000705) | 3.10348815 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 3.09987228 |
| 44 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.05785531 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 3.03809957 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.02151353 |
| 47 | Plantar hyperkeratosis (HP:0007556) | 3.00573269 |
| 48 | Late onset (HP:0003584) | 2.96025953 |
| 49 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.94007409 |
| 50 | Dicarboxylic aciduria (HP:0003215) | 2.94007409 |
| 51 | Epidermoid cyst (HP:0200040) | 2.93566721 |
| 52 | Abnormal hair laboratory examination (HP:0003328) | 2.93534432 |
| 53 | J-shaped sella turcica (HP:0002680) | 2.88222232 |
| 54 | Hypoalphalipoproteinemia (HP:0003233) | 2.86222758 |
| 55 | Type I transferrin isoform profile (HP:0003642) | 2.80016132 |
| 56 | Abnormality of complement system (HP:0005339) | 2.79820311 |
| 57 | Abnormality of vitamin B metabolism (HP:0004340) | 2.78640637 |
| 58 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.78048339 |
| 59 | Hyperphosphatemia (HP:0002905) | 2.77201022 |
| 60 | Fragile nails (HP:0001808) | 2.76878067 |
| 61 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.75525201 |
| 62 | Concave nail (HP:0001598) | 2.70032922 |
| 63 | Onycholysis (HP:0001806) | 2.65763997 |
| 64 | Chronic bronchitis (HP:0004469) | 2.61048652 |
| 65 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.60773948 |
| 66 | Hyperbilirubinemia (HP:0002904) | 2.60061450 |
| 67 | Steatorrhea (HP:0002570) | 2.58029016 |
| 68 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.54900343 |
| 69 | Hypercholesterolemia (HP:0003124) | 2.54548756 |
| 70 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.52557071 |
| 71 | Palmoplantar hyperkeratosis (HP:0000972) | 2.48819782 |
| 72 | Abnormality of methionine metabolism (HP:0010901) | 2.48136509 |
| 73 | Malnutrition (HP:0004395) | 2.46639560 |
| 74 | Methylmalonic acidemia (HP:0002912) | 2.45561641 |
| 75 | Hyperglycemia (HP:0003074) | 2.41475317 |
| 76 | Hyperparathyroidism (HP:0000843) | 2.39618039 |
| 77 | Flat acetabular roof (HP:0003180) | 2.38705125 |
| 78 | Megaloblastic anemia (HP:0001889) | 2.37420906 |
| 79 | Hypotrichosis (HP:0001006) | 2.36812491 |
| 80 | Lethargy (HP:0001254) | 2.36333738 |
| 81 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.36272889 |
| 82 | Woolly hair (HP:0002224) | 2.35808424 |
| 83 | Irritability (HP:0000737) | 2.35181277 |
| 84 | Conjunctival hamartoma (HP:0100780) | 2.34706105 |
| 85 | Myocardial infarction (HP:0001658) | 2.33560872 |
| 86 | Abnormality of urine glucose concentration (HP:0011016) | 2.32755432 |
| 87 | Glycosuria (HP:0003076) | 2.32755432 |
| 88 | Hyperthyroidism (HP:0000836) | 2.31968070 |
| 89 | Pancreatitis (HP:0001733) | 2.31417359 |
| 90 | Metabolic acidosis (HP:0001942) | 2.30886238 |
| 91 | Esophageal varix (HP:0002040) | 2.28043941 |
| 92 | Abnormality of nail color (HP:0100643) | 2.27557115 |
| 93 | Proximal tubulopathy (HP:0000114) | 2.26703572 |
| 94 | Glomerulonephritis (HP:0000099) | 2.26547167 |
| 95 | Hypoplasia of the uterus (HP:0000013) | 2.26385845 |
| 96 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.25961958 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.24092588 |
| 98 | Vascular calcification (HP:0004934) | 2.23972424 |
| 99 | Amyloidosis (HP:0011034) | 2.22563354 |
| 100 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21802360 |
| 101 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21802360 |
| 102 | Abnormal protein glycosylation (HP:0012346) | 2.21802360 |
| 103 | Abnormal glycosylation (HP:0012345) | 2.21802360 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.21156104 |
| 105 | Methylmalonic aciduria (HP:0012120) | 2.18775935 |
| 106 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17946327 |
| 107 | Mucopolysacchariduria (HP:0008155) | 2.17946327 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17289191 |
| 109 | Alopecia of scalp (HP:0002293) | 2.16611633 |
| 110 | Tongue fasciculations (HP:0001308) | 2.15930072 |
| 111 | Skin nodule (HP:0200036) | 2.15912676 |
| 112 | Palmar hyperkeratosis (HP:0010765) | 2.15612388 |
| 113 | Hydroxyprolinuria (HP:0003080) | 2.15406500 |
| 114 | Abnormality of proline metabolism (HP:0010907) | 2.15406500 |
| 115 | Opisthotonus (HP:0002179) | 2.14717568 |
| 116 | Acute encephalopathy (HP:0006846) | 2.11688508 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.11613296 |
| 118 | Abnormality of magnesium homeostasis (HP:0004921) | 2.11612679 |
| 119 | Oral leukoplakia (HP:0002745) | 2.10792419 |
| 120 | Flat capital femoral epiphysis (HP:0003370) | 2.10721084 |
| 121 | Hyperphosphaturia (HP:0003109) | 2.10228353 |
| 122 | Axonal loss (HP:0003447) | 2.10015662 |
| 123 | Vomiting (HP:0002013) | 2.09451794 |
| 124 | Mitochondrial inheritance (HP:0001427) | 2.09316410 |
| 125 | Hyperuricemia (HP:0002149) | 2.07550970 |
| 126 | Increased purine levels (HP:0004368) | 2.07550970 |
| 127 | Alkalosis (HP:0001948) | 2.07192767 |
| 128 | Nausea (HP:0002018) | 2.06140105 |
| 129 | Dysostosis multiplex (HP:0000943) | 2.06113363 |
| 130 | Reduced antithrombin III activity (HP:0001976) | 2.05286755 |
| 131 | Abnormality of the dental root (HP:0006486) | 2.05061447 |
| 132 | Taurodontia (HP:0000679) | 2.05061447 |
| 133 | Abnormality of permanent molar morphology (HP:0011071) | 2.05061447 |
| 134 | Abnormality of serum amino acid levels (HP:0003112) | 2.04448461 |
| 135 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.04266743 |
| 136 | Abnormal urine phosphate concentration (HP:0012599) | 2.03274986 |
| 137 | Hepatocellular carcinoma (HP:0001402) | 2.02810632 |
| 138 | Brushfield spots (HP:0001088) | 2.01079616 |
| 139 | Rhinitis (HP:0012384) | 1.99862858 |
| 140 | Acute necrotizing encephalopathy (HP:0006965) | 1.99812839 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.99655474 |
| 142 | Milia (HP:0001056) | 1.99380879 |
| 143 | Dehydration (HP:0001944) | 1.98246442 |
| 144 | Menorrhagia (HP:0000132) | 1.97316430 |
| 145 | Septate vagina (HP:0001153) | 1.95817355 |
| 146 | Elevated alkaline phosphatase (HP:0003155) | 1.95522459 |
| 147 | Cardiovascular calcification (HP:0011915) | 1.95479541 |
| 148 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95276094 |
| 149 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95276094 |
| 150 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95276094 |
| 151 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.95071863 |
| 152 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.95071863 |
| 153 | Insulin resistance (HP:0000855) | 1.94774830 |
| 154 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.92537113 |
| 155 | Hemorrhage of the eye (HP:0011885) | 1.92121564 |
| 156 | Cerebral edema (HP:0002181) | 1.91910829 |
| 157 | Microretrognathia (HP:0000308) | 1.91395977 |
| 158 | Increased hepatocellular lipid droplets (HP:0006565) | 1.90841291 |
| 159 | Abnormality of renin-angiotensin system (HP:0000847) | 1.90810972 |
| 160 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.89620586 |
| 161 | Hepatic necrosis (HP:0002605) | 1.88094797 |
| 162 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.87364866 |
| 163 | Abdominal distention (HP:0003270) | 1.86682791 |
| 164 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86663687 |
| 165 | Hyperactive renin-angiotensin system (HP:0000841) | 1.85478926 |
| 166 | Abnormal trabecular bone morphology (HP:0100671) | 1.85174515 |
| 167 | Hypoplasia of the pons (HP:0012110) | 1.84783394 |
| 168 | Decreased circulating renin level (HP:0003351) | 1.84721979 |
| 169 | Abnormal number of erythroid precursors (HP:0012131) | 1.84276063 |
| 170 | Hepatocellular necrosis (HP:0001404) | 1.83743328 |
| 171 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82380528 |
| 172 | Polycythemia (HP:0001901) | 1.81250136 |
| 173 | Nasolacrimal duct obstruction (HP:0000579) | 1.81188487 |
| 174 | Rough bone trabeculation (HP:0100670) | 1.80237633 |
| 175 | Abnormality of molar (HP:0011077) | 1.79885788 |
| 176 | Abnormality of molar morphology (HP:0011070) | 1.79885788 |
| 177 | Abnormality of iron homeostasis (HP:0011031) | 1.79861421 |
| 178 | Popliteal pterygium (HP:0009756) | 1.79047977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.92447699 |
| 2 | ERN1 | 4.61532997 |
| 3 | BCKDK | 4.06092853 |
| 4 | PIM2 | 3.18506418 |
| 5 | VRK2 | 3.15407378 |
| 6 | ARAF | 2.89011850 |
| 7 | MAPK15 | 2.81381925 |
| 8 | RIPK1 | 2.80347559 |
| 9 | INSRR | 2.79434640 |
| 10 | SMG1 | 2.60748003 |
| 11 | MAP3K12 | 2.48753791 |
| 12 | IRAK3 | 2.35791000 |
| 13 | LMTK2 | 2.12803702 |
| 14 | TLK1 | 2.09067247 |
| 15 | SIK1 | 2.02683138 |
| 16 | KDR | 1.96602742 |
| 17 | MST1R | 1.94118075 |
| 18 | MAP3K3 | 1.88748966 |
| 19 | NME2 | 1.88746846 |
| 20 | MAP3K11 | 1.88513044 |
| 21 | FLT3 | 1.86899764 |
| 22 | FGFR4 | 1.81370800 |
| 23 | PAK4 | 1.81067218 |
| 24 | TAOK3 | 1.80837995 |
| 25 | FRK | 1.76931626 |
| 26 | MAP2K2 | 1.65308035 |
| 27 | RPS6KB2 | 1.61133031 |
| 28 | EPHA2 | 1.59149949 |
| 29 | ZAK | 1.56937243 |
| 30 | BMPR1B | 1.55805996 |
| 31 | TRIB3 | 1.41763407 |
| 32 | BRAF | 1.41697913 |
| 33 | DYRK1B | 1.40239137 |
| 34 | TYK2 | 1.39810719 |
| 35 | EIF2AK1 | 1.32410619 |
| 36 | PTK6 | 1.30215046 |
| 37 | TGFBR2 | 1.25949630 |
| 38 | AKT3 | 1.24780926 |
| 39 | TEC | 1.24377568 |
| 40 | GRK1 | 1.23299468 |
| 41 | PIK3CG | 1.21078312 |
| 42 | MAP2K3 | 1.19755200 |
| 43 | WNK4 | 1.19654539 |
| 44 | SCYL2 | 1.16264396 |
| 45 | MAPKAPK3 | 1.13701760 |
| 46 | MET | 1.13106314 |
| 47 | ACVR1B | 1.12799448 |
| 48 | TBK1 | 1.08900144 |
| 49 | PRKD3 | 1.08285997 |
| 50 | LIMK1 | 1.02780635 |
| 51 | AURKA | 1.00607613 |
| 52 | BMX | 0.99878870 |
| 53 | LATS2 | 0.99876372 |
| 54 | TESK1 | 0.99469054 |
| 55 | PASK | 0.98152545 |
| 56 | CSK | 0.97845187 |
| 57 | EPHB1 | 0.96605541 |
| 58 | ICK | 0.96085605 |
| 59 | MAP3K14 | 0.95095338 |
| 60 | DAPK3 | 0.91757831 |
| 61 | MUSK | 0.91056058 |
| 62 | ZAP70 | 0.89129879 |
| 63 | DAPK1 | 0.88411591 |
| 64 | LATS1 | 0.85975570 |
| 65 | MAPK11 | 0.85372203 |
| 66 | MAP3K1 | 0.84357805 |
| 67 | IRAK4 | 0.83257459 |
| 68 | ABL2 | 0.81709576 |
| 69 | PRKD2 | 0.79861405 |
| 70 | BUB1 | 0.75960974 |
| 71 | VRK1 | 0.75882725 |
| 72 | TRPM7 | 0.73505661 |
| 73 | ILK | 0.71929865 |
| 74 | EIF2AK3 | 0.71878276 |
| 75 | CDK9 | 0.71163927 |
| 76 | TESK2 | 0.68952657 |
| 77 | CAMK1D | 0.68870535 |
| 78 | PKN2 | 0.65654159 |
| 79 | PDK2 | 0.64916201 |
| 80 | HIPK2 | 0.63164440 |
| 81 | PHKG2 | 0.63130617 |
| 82 | PHKG1 | 0.63130617 |
| 83 | BTK | 0.63026852 |
| 84 | MATK | 0.62374668 |
| 85 | IKBKB | 0.62063029 |
| 86 | JAK2 | 0.60437983 |
| 87 | GSK3A | 0.59376891 |
| 88 | ERBB4 | 0.59328369 |
| 89 | PRKCI | 0.58468983 |
| 90 | PBK | 0.58371216 |
| 91 | PTK2 | 0.58291562 |
| 92 | TAOK1 | 0.57666610 |
| 93 | PRKG2 | 0.57430344 |
| 94 | LRRK2 | 0.57214206 |
| 95 | DDR2 | 0.56908468 |
| 96 | MST4 | 0.56833577 |
| 97 | AKT2 | 0.56704470 |
| 98 | IRAK1 | 0.55797582 |
| 99 | AURKB | 0.54561653 |
| 100 | MAP3K2 | 0.52758090 |
| 101 | STK38L | 0.52339747 |
| 102 | TAF1 | 0.52293512 |
| 103 | NEK6 | 0.52151264 |
| 104 | MELK | 0.51846045 |
| 105 | CAMK2G | 0.50863951 |
| 106 | BLK | 0.50662376 |
| 107 | IKBKE | 0.49646482 |
| 108 | JAK1 | 0.48208784 |
| 109 | DYRK3 | 0.47211150 |
| 110 | STK38 | 0.46868496 |
| 111 | JAK3 | 0.46566034 |
| 112 | WNK3 | 0.45573003 |
| 113 | PDGFRA | 0.44511512 |
| 114 | STK16 | 0.44239695 |
| 115 | STK39 | 0.44070621 |
| 116 | CDK7 | 0.44054590 |
| 117 | CAMK2D | 0.41873619 |
| 118 | MAPKAPK2 | 0.41550934 |
| 119 | PIM1 | 0.39847013 |
| 120 | STK4 | 0.39454109 |
| 121 | MAPK4 | 0.39000451 |
| 122 | PRKD1 | 0.38743087 |
| 123 | MAP2K6 | 0.38148220 |
| 124 | PRKAA2 | 0.36912524 |
| 125 | EPHB2 | 0.36714178 |
| 126 | CSF1R | 0.36396745 |
| 127 | CSNK1A1 | 0.35516091 |
| 128 | STK24 | 0.35423594 |
| 129 | FER | 0.34455016 |
| 130 | EPHA3 | 0.34438099 |
| 131 | EEF2K | 0.34232772 |
| 132 | MAP4K1 | 0.34081373 |
| 133 | MAP2K1 | 0.33496189 |
| 134 | MYLK | 0.32690676 |
| 135 | PRKCD | 0.32626016 |
| 136 | CHUK | 0.31884428 |
| 137 | TTK | 0.30614724 |
| 138 | TNK2 | 0.30068274 |
| 139 | TAOK2 | 0.30014254 |
| 140 | MAP3K5 | 0.29953171 |
| 141 | PINK1 | 0.29435278 |
| 142 | EGFR | 0.27428960 |
| 143 | GRK6 | 0.27329547 |
| 144 | DMPK | 0.24897684 |
| 145 | NUAK1 | 0.24654484 |
| 146 | NME1 | 0.23852936 |
| 147 | RPS6KC1 | 0.23004340 |
| 148 | RPS6KL1 | 0.23004340 |
| 149 | PRKACG | 0.22079925 |
| 150 | IRAK2 | 0.21984423 |
| 151 | PRKCZ | 0.21833459 |
| 152 | PDPK1 | 0.21708695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.51116316 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.12069922 |
| 3 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.84889125 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.80515067 |
| 5 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.51620694 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46768779 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.46734959 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.35899225 |
| 9 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.30193084 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26656992 |
| 11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24386977 |
| 12 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.23612999 |
| 13 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.20529727 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.19317002 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.15467830 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 2.13372679 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12994059 |
| 18 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.09338666 |
| 19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.07213232 |
| 20 | Peroxisome_Homo sapiens_hsa04146 | 2.07199531 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.96897745 |
| 22 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.93658974 |
| 23 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.88270133 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.81827207 |
| 25 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.75789113 |
| 26 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75604050 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.74642047 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73522058 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72286849 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.69448106 |
| 31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69026250 |
| 32 | Sulfur relay system_Homo sapiens_hsa04122 | 1.65926060 |
| 33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.65874985 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64071314 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.62965575 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.60992264 |
| 37 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58991005 |
| 38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.57980699 |
| 39 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57696392 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55122952 |
| 41 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53067644 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.52558574 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.46767902 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43892744 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.41974465 |
| 46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.38648321 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38128418 |
| 48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.35421430 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.34114900 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 1.30369715 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.29168191 |
| 52 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.28544663 |
| 53 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.25189158 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.24877108 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.22540859 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22367255 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.12695095 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.02298419 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.00313916 |
| 60 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.99624741 |
| 61 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.96853245 |
| 62 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.95419252 |
| 63 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.93191120 |
| 64 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.92599688 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91901030 |
| 66 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91054643 |
| 67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.87620567 |
| 68 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85817700 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.85448802 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.82384616 |
| 71 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.79868260 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79157506 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.77201344 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75717795 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74749332 |
| 76 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74540654 |
| 77 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72421749 |
| 78 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71801616 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71544679 |
| 80 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67770800 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.67510410 |
| 82 | Tight junction_Homo sapiens_hsa04530 | 0.66694268 |
| 83 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.66620677 |
| 84 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.64460218 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.64347781 |
| 86 | Lysosome_Homo sapiens_hsa04142 | 0.63279956 |
| 87 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.63085092 |
| 88 | RNA polymerase_Homo sapiens_hsa03020 | 0.60719530 |
| 89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.59381381 |
| 90 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.58593478 |
| 91 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58118557 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53583423 |
| 93 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53388318 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.45599976 |
| 95 | Purine metabolism_Homo sapiens_hsa00230 | 0.45044940 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.44737616 |
| 97 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44389190 |
| 98 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44253396 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.40551036 |
| 100 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40071343 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.39677679 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.38069412 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.31909925 |
| 104 | RNA transport_Homo sapiens_hsa03013 | 0.31272163 |
| 105 | Mineral absorption_Homo sapiens_hsa04978 | 0.30000085 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | 0.29743563 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.29649227 |
| 108 | Mismatch repair_Homo sapiens_hsa03430 | 0.28324760 |
| 109 | Lysine degradation_Homo sapiens_hsa00310 | 0.27501525 |
| 110 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.24074441 |
| 111 | DNA replication_Homo sapiens_hsa03030 | 0.23312557 |
| 112 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22919726 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22544994 |
| 114 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.20965551 |
| 115 | Hepatitis C_Homo sapiens_hsa05160 | 0.16960623 |
| 116 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.16356333 |
| 117 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15552230 |
| 118 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.15492563 |
| 119 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.11954605 |
| 120 | Pertussis_Homo sapiens_hsa05133 | 0.09155636 |
| 121 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.06818017 |
| 122 | Bladder cancer_Homo sapiens_hsa05219 | 0.06628233 |
| 123 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.06363217 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.06232420 |
| 125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.05499227 |
| 126 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.04771477 |

